This study found no statistically significant association between the BRAF V600E/Ec mutation and any of the five clinical markers (largest foci diameter, age, Tg, antiTg, and Tg/TSH), suggesting that this mutation does not strongly correlate with key clinical features like tumor size or biomarker levels (p > 0.05). This evidence concerns the gene TG and neoplasm.